Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v4-FR | Version v3-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2020-11-12 | 2020-11-12 |
| Drug Identification Number | 01934740 | 01934740 |
| Brand name | ROBITUSSIN AC | ROBITUSSIN AC |
| Common or Proper name | Guaifenesin, Codeine Phosphate and Pheniramine Maleate Syrup | Guaifenesin, Codeine Phosphate and Pheniramine Maleate Syrup |
| Company Name | GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC | GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC |
| Ingredients | CODEINE PHOSPHATE GUAIFENESIN PHENIRAMINE MALEATE | CODEINE PHOSPHATE GUAIFENESIN PHENIRAMINE MALEATE |
| Strength(s) | 10MG 100MG 7.5MG | 10MG 100MG 7.5MG |
| Dosage form(s) | SYRUP | SYRUP |
| Route of administration | ORAL | ORAL |
| Packaging size | 1 Litre | 1 Litre |
| ATC code | R05FA | R05FA |
| ATC description | COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS | COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | ||
| Actual start date | 2019-10-09 | 2019-10-09 |
| Estimated end date | 2020-01-31 | 2020-01-31 |
| Actual end date | 2020-01-03 | 2020-01-03 |
| Shortage status | Resolved | Resolved |
| Tier 3 Status | No | No |
| Company comments | Manufacturing disruption has been rectified. | Manufacturing disruption has been rectified. |
| Health Canada comments |